Brooks Steriscience Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BROOKS STERISCIENCE
BROOKS STERISCIENCE has two approved drugs.
Drugs and US Patents for Brooks Steriscience
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brooks Steriscience | MEROPENEM | meropenem | INJECTABLE;INJECTION | 216154-001 | Aug 18, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Brooks Steriscience | MEROPENEM | meropenem | POWDER;INTRAVENOUS | 219084-001 | Jun 23, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Brooks Steriscience | MEROPENEM | meropenem | INJECTABLE;INJECTION | 216154-002 | Aug 18, 2022 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

